Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Hahn

Showing results (121-130 of 128) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 128 results.
Nature Cancer|February 5, 2022
Tryptophan metabolism drives dynamic immunosuppressive myeloid states in IDH-mutant gliomasMirco Friedrich, Roman Sankowski, Lukas Bunse, et al.
European Journal of Cancer (Oxford, England : 1990)|July 15, 2021
Disseminated tumour cells from the bone marrow of early breast cancer patients: Results from an international pooled analysisAndreas D Hartkopf, Sara Y Brucker, Florin-Andrei Taran, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 30, 2025
Lost axillary markers after neoadjuvant chemotherapy in breast cancer patients - data from the prospective international AXSANA (EUBREAST 3) cohort study (NCT04373655)Steffi Hartmann, Maggie Banys-Paluchowski, Tomasz Berger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2026
Marking Techniques for Target Lymph Nodes in Node-Positive Breast Cancer Treated With Neoadjuvant Therapy in the AXSANA/EUBREAST-03/AGO-B-053 StudyMaggie Banys-Paluchowski, Steffi Hartmann, Jana de Boniface, et al.
The British Journal of Surgery|September 18, 2025
Axillary dissection for low-volume nodal involvement after neoadjuvant therapy in breast cancer: multicentre AXSANA cohort studyThorsten Kühn, Maggie Banys-Paluchowski, Nina Ditsch, et al.
Haematologica|December 6, 2018
Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IVChristian Michel, Andreas Burchert, Andreas Hochhaus, et al.
Geburtshilfe Und Frauenheilkunde|December 25, 2018
Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast CancerAchim Wöckel, Jasmin Festl, Tanja Stüber, et al.
Geburtshilfe Und Frauenheilkunde|October 30, 2018
Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast CancerAchim Wöckel, Jasmin Festl, Tanja Stüber, et al.
Pageof 13

Showing results (121-130 of 128) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 128 results.
Nature Cancer|February 5, 2022
Tryptophan metabolism drives dynamic immunosuppressive myeloid states in IDH-mutant gliomasMirco Friedrich, Roman Sankowski, Lukas Bunse, et al.
European Journal of Cancer (Oxford, England : 1990)|July 15, 2021
Disseminated tumour cells from the bone marrow of early breast cancer patients: Results from an international pooled analysisAndreas D Hartkopf, Sara Y Brucker, Florin-Andrei Taran, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 30, 2025
Lost axillary markers after neoadjuvant chemotherapy in breast cancer patients - data from the prospective international AXSANA (EUBREAST 3) cohort study (NCT04373655)Steffi Hartmann, Maggie Banys-Paluchowski, Tomasz Berger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2026
Marking Techniques for Target Lymph Nodes in Node-Positive Breast Cancer Treated With Neoadjuvant Therapy in the AXSANA/EUBREAST-03/AGO-B-053 StudyMaggie Banys-Paluchowski, Steffi Hartmann, Jana de Boniface, et al.
The British Journal of Surgery|September 18, 2025
Axillary dissection for low-volume nodal involvement after neoadjuvant therapy in breast cancer: multicentre AXSANA cohort studyThorsten Kühn, Maggie Banys-Paluchowski, Nina Ditsch, et al.
Haematologica|December 6, 2018
Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IVChristian Michel, Andreas Burchert, Andreas Hochhaus, et al.
Geburtshilfe Und Frauenheilkunde|December 25, 2018
Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast CancerAchim Wöckel, Jasmin Festl, Tanja Stüber, et al.
Geburtshilfe Und Frauenheilkunde|October 30, 2018
Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast CancerAchim Wöckel, Jasmin Festl, Tanja Stüber, et al.
Pageof 13